Literature DB >> 9727816

Should pericardial drainage be performed routinely in patients who have a large pericardial effusion without tamponade?

J Mercé1, J Sagristà-Sauleda, G Permanyer-Miralda, J Soler-Soler.   

Abstract

PURPOSE: To assess whether drainage of pericardial effusion by pericardiocentesis or surgery is justified as a routine measure in the initial management of patients with large pericardial effusion without tamponade or suspected purulent pericarditis. SUBJECTS AND METHODS: All patients with large pericardial effusion without tamponade or suspected purulent pericarditis who were seen at our institution during a span of 6 years (1990 to 1995) were retrospectively (46) or prospectively (25) reviewed. Large pericardial effusion was defined as a sum of echo-free pericardial spaces in diastole exceeding 20 mm.
RESULTS: Large pericardial effusion was diagnosed in 162 patients, 71 of whom fulfilled criteria for inclusion. Of these, 26 underwent a pericardial drainage procedure. Diagnostic yield was 7%, as only 2 specific diagnoses were made using these procedures. During follow-up (95% of patients, median 10 months), no patient developed cardiac tamponade or died as a result of pericardial disease, nor did any new diagnoses become manifest in the 45 patients who did not have pericardial drainage initially. Moderate or large effusions persisted in only 2 of 45 patients managed conservatively.
CONCLUSIONS: Routine pericardial drainage procedures have a very low diagnostic yield in patients with large pericardial effusion without tamponade or suspected purulent pericarditis, and no clear therapeutic benefit is obtained with this approach. Clinical outcomes depend on underlying diseases, and do not appear to be influenced by drainage of pericardial fluid.

Entities:  

Mesh:

Year:  1998        PMID: 9727816     DOI: 10.1016/s0002-9343(98)00192-2

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  19 in total

1.  Cardiac tamponade as the first manifestation of gastric cancer and remission after chemotherapy.

Authors:  N Varvarigos; H Kamaradou; A Kourti; E D Papavasiliou; H Papaioannou; I N Migdalis; C Galanis
Journal:  Dig Dis Sci       Date:  2001-11       Impact factor: 3.199

Review 2.  Management of pericardial effusion.

Authors:  J Soler-Soler; J Sagristà-Sauleda; G Permanyer-Miralda
Journal:  Heart       Date:  2001-08       Impact factor: 5.994

Review 3.  Practical aspects of the management of pericardial disease.

Authors:  Bernhard Maisch; Arsen D Ristić
Journal:  Heart       Date:  2003-09       Impact factor: 5.994

Review 4.  Acute pericardial disease: approach to the aetiologic diagnosis.

Authors:  G Permanyer-Miralda
Journal:  Heart       Date:  2004-03       Impact factor: 5.994

5.  Pericardial disease: what the general cardiologist needs to know.

Authors:  Emma L Ivens; Bradley I Munt; Robert R Moss
Journal:  Heart       Date:  2007-08       Impact factor: 5.994

6.  CT directed diagnostic and therapeutic pericardiocentesis: 8-year experience at a single institution.

Authors:  S V Klein; H Afridi; D Agarwal; B F Coughlin; L H Schielke
Journal:  Emerg Radiol       Date:  2005-07-16

7.  Role of tissue characterization by Cardiac Magnetic Resonance in the diagnosis of constrictive pericarditis.

Authors:  Giovanni Donato Aquaro; Andrea Barison; Alessandro Cagnolo; Giancarlo Todiere; Massimo Lombardi; Michele Emdin
Journal:  Int J Cardiovasc Imaging       Date:  2015-04-01       Impact factor: 2.357

8.  Diagnosis and management of pericardial effusion.

Authors:  Jaume Sagristà-Sauleda; Axel Sarrias Mercé; Jordi Soler-Soler
Journal:  World J Cardiol       Date:  2011-05-26

9.  Case report: cardiac tamponade resembling an acute myocardial infarction as the initial manifestation of metastatic pericardial adenocarcinoma.

Authors:  Scott A Scheinin; Jose Sosa-Herrera
Journal:  Methodist Debakey Cardiovasc J       Date:  2014 Apr-Jun

10.  Evaluation of intrapericardial cisplatin administration in cases with recurrent malignant pericardial effusion and cardiac tamponade.

Authors:  Witold Zbyszek Tomkowski; Joanna Wiśniewska; Monika Szturmowicz; Paweł Kuca; Janusz Burakowski; Jarosław Kober; Anna Fijałkowska
Journal:  Support Care Cancer       Date:  2003-09-23       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.